CTOs on the Move

Molnlycke

www.molnlycke.com

 
A world-leading medical solutions company We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.molnlycke.com
  • 5550 Peachtree Pkwy Ste 500
    Norcross, GA USA 30092
  • Phone: 678.250.7900

Executives

Name Title Contact Details

Similar Companies

Xoran Technologies

Xoran Technologies, Inc. is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alpha Scientific Medical

Alpha Scientific Medical, Inc is a La Verne, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ZOLL

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims in need of resuscitation and critical care. We are looking for strong candidates who take initiative to continuously improve what they do in an effort to meet our customers` needs. We offer the challenge of working in a fast-paced team environment where your energy and expertise can help you to reach your full potential.

HemoSense

HemoSense is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CeQur

CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.